LipoCoat Holdings has acquired Sono-Coat, enhancing its portfolio with innovative echogenic coating solutions aimed at improving medical device functionality.

Information on the Target

LipoCoat Holdings, a portfolio company under 819 Capital Partners, has strategically acquired Sono-Coat, a pioneering firm known for its innovative echogenic coating solutions. Sono-Coat BV has developed patented technologies that greatly enhance ultrasound visibility for medical devices, which is essential for novel ultrasound-guided therapies.

This acquisition allows LipoCoat to significantly expand its scope and align with its mission to enhance the comfort, safety, and performance of medical devices through specialized coating solutions. This strategic move addresses the dynamic needs of researchers, clinicians, and patients globally.

Industry Overview in the Target’s Specific Country

The medical device industry in the Netherlands, where Sono-Coat is based, is witnessing rapid growth fueled by increasing investments in healthcare technology and innovati